Found: 5
Select item for more details and to access through your institution.
An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis.
- Published in:
- Gene Therapy, 2013, v. 20, n. 11, p. 1033, doi. 10.1038/gt.2013.28
- By:
- Publication type:
- Article
Reduced toxicity of F-deficient Sendai virus vector in the mouse fetus.
- Published in:
- Gene Therapy, 2004, v. 11, n. 7, p. 599, doi. 10.1038/sj.gt.3302205
- By:
- Publication type:
- Article
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 9, p. 373, doi. 10.1038/cgt.2014.40
- By:
- Publication type:
- Article
Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 3, p. 181, doi. 10.1038/cgt.2011.75
- By:
- Publication type:
- Article
Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 8, p. 598, doi. 10.1038/cgt.2011.30
- By:
- Publication type:
- Article